Receptor Theories
Receptor Theories
Introduction
Receptor Theories: Theoretical frameworks to understand drug action through interaction with receptors.
Key Contributors:
John Langley (1878): Proposed the term "receptive substance"; laid the groundwork for receptor theory in drug action.
Paul Ehrlich (1854-1915): Extended receptor theory through his work on cellular interactions and won a Nobel Prize in Physiology or Medicine in 1908.
Side-Chain Theory by Paul Ehrlich
Core Concept:
Described as the "side-chain theory" of cellular interaction.
Illustrated at the Royal Society of London in 1900.
Mechanism:
Immune cells possess many receptors specific to different substances.
Upon interaction with a toxin, the corresponding receptor activates the cell.
Activated cells produce more receptors, which are released into the bloodstream as antibodies to neutralize the toxin.
Classical Theories of Drug-Receptor Binding Interactions
Overview: Various theoretical frameworks explaining how drugs bind to receptors and elicit responses.
Occupation Theory
Definition: Drugs act on independent binding sites, activating them.
Key Points:
Biological response is proportional to the drug-receptor complex formed.
Response ceases when the complex dissociates.
The drug effect is directly proportional to the number of receptors occupied.
Lock and Key Concept
Origin: Introduced by Emil Fischer in 1894.
Analogy:
Lock: Enzyme
Key: Substrate
Function: Enzymes and substrates must fit together perfectly to exert a chemical reaction.
Illustration:
Correct fit results in a reaction.
Incorrect substrates do not react.
Quote by Emil Fischer:
“To use a picture, I would like to say that enzyme and glucoside have to fit like a lock and key, in order to exert a chemical action on each other.”
Rate Theory
Definition: Response is proportional to the rate of drug-receptor complex formation rather than the number of receptors occupied.
Key Points:
Pharmacological activity depends on the rates of dissociation and association.
The duration of receptor occupation determines whether the molecule acts as:
Agonist: Fast association and fast dissociation.
Partial Agonist: Intermediate association and intermediate dissociation.
Antagonist: Fast association and slow dissociation.
Induced-Fit Theory
Definition: The receptor's binding site may not be fully complementary to the ligand initially.
Mechanism:
Binding causes both ligand and receptor to change shape (dynamic process).
This conformational change leads to biological effects, moving away from the rigid "key and lock" concept.
Macromolecular Perturbation Theory
Core Concept: Drug-receptor interactions can cause two types of perturbations:
Conformational Perturbation: Specific changes that lead to a biological response (agonist).
Non-specific Conformational Perturbation: Changes that do not lead to any response (antagonist).
Activation-Aggregation Theory
Overview: Extends the macromolecular perturbation theory.
Key Points:
Receptors exist in equilibrium between activated (bioactive) and inactivated (bio-inactive) states; agonists bind to activated states, antagonists to inactivated states.
Receptor Signaling Dependency:
Activation: Conformational change.
Aggregation: Dimerization/oligomerization/clustering enhanced by ligand binding.
Particularly relevant for receptor tyrosine kinases (RTKs), immune receptors (e.g., Fc receptors), and cytokine receptors.
Molecular-Level Conceptual Models of Receptors
Core Concept: Receptors are not mere macromolecules but are dynamic structures.
Characteristics:
Many receptors are families of low-energy conformers existing in equilibrium.
Some receptors have complex multi-unit structures allowing for facilitatory and inhibitory interactions that can change drug-receptor dynamics.
Receptors may also be mobile, drifting within the membrane.
Two-State Receptor Model (Classical Pharmacology)
Definition: Receptors exist in two states, the resting state (R) and activated state (R*).
The equilibrium lies towards R in the absence of ligand; few are in R* state (except constitutively active receptors).
Agonists/Antagonists:
Agonist: Exhibits a high affinity for R*, shifting equilibrium rightward.
Antagonist: Equal affinity for both R and R*, does not alter the equilibrium.
Inverse Agonist: Has a higher affinity for R, shifting equilibrium leftward.
Contrast to Occupation Theory: Agonists do not directly activate receptors but instead shift the equilibrium toward R*.